Different sampling time points and Blinding [Bioanalytics]

posted by Pharma_88 – India, 2020-12-11 05:22 (129 d 11:40 ago) – Posting: # 22138
Views: 819

Dear all,

Please provide your suggestion for below concern.

for the bioequivalence studies, Analyst is always blind despite of regulatory requirement. By keeping different sampling time points i.e. 20 time-points for test and 22 time points for reference, whether analyst will blind in this condition?


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Monday 18:02 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5